VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 390 filers reported holding VIKING THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,413,729 | +9.6% | 102,127 | +69.5% | 0.00% | 0.0% |
Q1 2024 | $4,941,408 | +821.9% | 60,261 | +109.2% | 0.00% | – |
Q4 2023 | $535,987 | -61.5% | 28,801 | -77.1% | 0.00% | – |
Q3 2023 | $1,393,459 | -14.4% | 125,877 | +25.4% | 0.00% | – |
Q2 2023 | $1,627,127 | +7.5% | 100,378 | +10.4% | 0.00% | – |
Q1 2023 | $1,513,402 | +10604.5% | 90,895 | +5943.6% | 0.00% | – |
Q4 2022 | $14,138 | +371.3% | 1,504 | +25.5% | 0.00% | – |
Q3 2022 | $3,000 | -66.7% | 1,198 | -62.7% | 0.00% | – |
Q2 2022 | $9,000 | -94.8% | 3,211 | -94.4% | 0.00% | – |
Q1 2022 | $174,000 | -53.0% | 57,842 | -28.2% | 0.00% | – |
Q4 2021 | $370,000 | -48.3% | 80,508 | -29.3% | 0.00% | – |
Q3 2021 | $716,000 | -6.3% | 113,841 | -10.6% | 0.00% | – |
Q2 2021 | $764,000 | -36.9% | 127,394 | -33.5% | 0.00% | – |
Q1 2021 | $1,211,000 | -27.5% | 191,533 | -35.4% | 0.00% | – |
Q4 2020 | $1,670,000 | +16.5% | 296,462 | +20.4% | 0.00% | – |
Q3 2020 | $1,433,000 | -22.4% | 246,275 | -3.9% | 0.00% | -100.0% |
Q2 2020 | $1,847,000 | +73.9% | 256,140 | +12.9% | 0.00% | – |
Q1 2020 | $1,062,000 | -43.8% | 226,905 | -3.6% | 0.00% | -100.0% |
Q4 2019 | $1,888,000 | +7.5% | 235,262 | -7.9% | 0.00% | – |
Q3 2019 | $1,756,000 | -14.0% | 255,381 | +3.9% | 0.00% | -100.0% |
Q2 2019 | $2,041,000 | -34.4% | 245,751 | -21.5% | 0.00% | 0.0% |
Q1 2019 | $3,113,000 | +39.4% | 313,101 | +7.3% | 0.00% | 0.0% |
Q4 2018 | $2,233,000 | +94.9% | 291,864 | +343.5% | 0.00% | – |
Q3 2018 | $1,146,000 | +105.4% | 65,810 | +12.0% | 0.00% | – |
Q2 2018 | $558,000 | +6100.0% | 58,773 | +840.4% | 0.00% | – |
Q3 2016 | $9,000 | +12.5% | 6,250 | 0.0% | 0.00% | – |
Q2 2016 | $8,000 | -11.1% | 6,250 | 0.0% | 0.00% | – |
Q1 2016 | $9,000 | -57.1% | 6,250 | 0.0% | 0.00% | – |
Q4 2015 | $21,000 | – | 6,250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |